Clinical Trial Details

Trial ID: L0501
Source ID: TCTR20180425001
Associated Drug: Atorvastatin
Title: Evaluation of the benefit of supplementation with alpha-tocopherol and ascorbic acid to non-alcoholic fatty liver disease????????s statin therapy in men - Randomized Controlled Trial.
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: Non-alcoholic fatty liver disease (NAFLD)
Interventions: 20 mg atorvastatin daily,20 mg atorvastatin daily + 400 IU of vitamin E and 1000 mg of vitamin C daily,Healthy controls.;Active Comparator Drug,Experimental Drug,No Intervention No treatment;Atorvastatin,Atorvastatin+vitC+vit E,Control
Outcome Measures: Normalization of the activity of antioxidant enzymes At the end of the intervention Enzyme activityNormalization of the serum lipid profile At the end of the intervention Concentration in serum,Normalization of the aminotransferase levels At the end of the intervention Activity in serum,Normalization of CRP levels At the end of the intervention Concentration in serum
Sponsor/Collaborators: Ss. Cyril and Methodius University in Skopje
Gender: Male
Age: 35 Years60 Years
Phases: Not applicable
Enrollment: --
Study Type: Interventional
Study Designs: Randomized
Start Date: 25/04/2018
Completion Date: 31/12/2017
Results First Posted: --
Last Update Posted: 7 February 2022
Locations: Republic of Macedonia
URL: www.thaiclinicaltrials.org/show/TCTR20180425001